These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8693551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced survival of grafts genetically endowed with the ability to block CD2 and B7.
    Brady JL, Yamashita K, Lew AM.
    Cell Transplant; 2001; 10(2):175-81. PubMed ID: 11332632
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.
    Transplantation; 2001 Jun 15; 71(11):1656-65. PubMed ID: 11435979
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD mice.
    Koulmanda M, Kovarik J, Mandel TE.
    Xenotransplantation; 1998 Aug 15; 5(3):215-21. PubMed ID: 9741460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S.
    Transplantation; 2001 Oct 27; 72(8):1423-32. PubMed ID: 11685115
    [Abstract] [Full Text] [Related]

  • 9. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA.
    J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts.
    Sutherland RM, Brady JL, Georgiou HM, Thomas HE, Lew AM.
    Transplantation; 2000 May 15; 69(9):1806-12. PubMed ID: 10830215
    [Abstract] [Full Text] [Related]

  • 11. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 12. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep 27; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 13. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig.
    Feng S, Quickel RR, Hollister-Lock J, McLeod M, Bonner-Weir S, Mulligan RC, Weir GC.
    Transplantation; 1999 Jun 27; 67(12):1607-13. PubMed ID: 10401769
    [Abstract] [Full Text] [Related]

  • 14. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA.
    J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826
    [Abstract] [Full Text] [Related]

  • 15. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T, Räisänen-Sokolowski A, Sayegh MH, Russell ME.
    Transplantation; 1997 Dec 27; 64(12):1641-5. PubMed ID: 9422395
    [Abstract] [Full Text] [Related]

  • 16. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.
    Perico N, Imberti O, Bontempelli M, Remuzzi G.
    Kidney Int; 1995 Jan 27; 47(1):241-6. PubMed ID: 7731152
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
    Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA.
    J Exp Med; 1995 Mar 01; 181(3):1145-55. PubMed ID: 7532678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.